Q06187 (BTK_HUMAN) Homo sapiens (Human)

Tyrosine-protein kinase BTK UniProtKBInterProSTRINGInteractive Modelling

659 aa; Sequence (Fasta) ; (Isoform 2); 10 identical sequences: Pan troglodytes: A0A2I3RVY9; Pan paniscus: A0A2R9BPC2; Gorilla gorilla gorilla: G3SKC9; Mandrillus leucophaeus: A0A2K6A443; Macaca nemestrina: A0A2K6CUV5; Macaca mulatta: F6V0I6, A0A8J8YBS4; Macaca fascicularis: A0A2K5VDZ2; Nomascus leucogenys: G1R7I9; Rhinopithecus roxellana: A0A2K6PTH4

Available Structures

123 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihyd…
5j87
 Heteromer
385-658
4×N42;
Assess
Structure of cIAP1, BTK and BCCov
8dso
 Heteromer
Q13490; 		392-659
1×TOO; 1×ZN;
Assess
Ternary complex structure - BTK cIAP compound 15
6w8i
 Heteromer
Q13490; 		393-657
1×ZN; 1×TKY;
Assess
Ternary complex structure - BTK cIAP compound 17
6w7o
 Heteromer
Q13490; 		396-656
1×TL7; 1×ZN;
Assess
Crystal structure of human Btk SH2 domain bound to rF10 repebody
6htf
 Heteromer
276-379
Assess
PH DOMAIN AND BTK MOTIF FROM BRUTON'S TYROSINE KINASE MUTANT E41K IN COMPLEX WITH INS(1,3,4,5)P4
1bwn
homo-4-mer2-170
4×ZN; 8×4IP;
Assess
PH DOMAIN FROM BRUTON'S TYROSINE KINASE IN COMPLEX WITH INOSITOL 1,3,4,5-TETRAKISPHOSPHATE
1b55
homo-4-mer2-170
4×ZN; 4×4IP;
Assess
The structure of human BTK kinase domain in complex with a covalent inhibitor
5xyz
homo-2-mer394-656
2×GYL;
Assess
CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO …
5jrs
homo-2-mer396-656
2×6MV;
Assess
Crystal structure of Bruton's tyrosine kinase domain
1k2p
homo-2-mer397-654
Assess
PH DOMAIN AND BTK MOTIF FROM BRUTON'S TYROSINE KINASE MUTANT R28C
1btk
homo-2-mer2-170
2×ZN; 2×NA;
Assess
CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT FRAGMENT LIGAND
6di1
monomer389-659
1×GJD;
Assess
BTK1 SOAKED WITH IBRUTINIB-Rev
5p9i
monomer389-659
1×1E8; 2×DMS;
Assess
CRYSTAL STRUCTURE OF BTK with CNX 774
5p9k
monomer389-659
1×7G8;
Assess
CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH FRAGMENT LIGAND
6di0
monomer389-659
1×GJG;
Assess
BTK1 SOAKED WITH COMPOUND 5, Y551 IS SEQUESTERED
7kxm
monomer389-659
1×X9M;
Assess
Discovery of a potent BTK inhibitor with a novel binding mode using parallel selections with a DNA-…
5u9d
monomer389-659
1×83P; 3×EDO; 2×PEG;
Assess
BTK in complex with inhibitor 8-(2,3-dihydro-1H-inden-5-yl)-2-({4-[(2S)-3-(dimethylamino)-2-hydroxy…
6nfh
monomer389-659
1×KLM; 6×EDO;
Assess
BTK1 BINDS COVALENTLY TO HY-15771 ONO-4059
5p9m
monomer389-659
1×7GB; 1×DMS;
Assess
Structure of human Bruton's Tyrosine Kinase in complex with Evobrutinib
6omu
monomer389-659
1×CL; 1×MZJ;
Assess
CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT INHIBITOR
6di5
monomer389-659
1×GJ7; 1×DMS;
Assess
Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R…
5bq0
monomer389-659
1×4US; 1×DMS; 2×EDO;
Assess
Bruton's tyrosine kinase (BTK) with GDC-0853
5vfi
monomer389-659
1×9AJ; 8×EDO; 2×SO4;
Assess
Fragment-Based Discovery of a Small Molecule Reversible Inhibitor of Bruton's Tyrosine Kinase
4z3v
monomer389-659
2×IMD; 1×IPA; 1×EDO; 1×4L6;
Assess
BTK1 SOAKED WITH COMPOUND 25
7kxp
monomer389-659
1×X9V; 4×DMS;
Assess
BTK in complex with 18A
7r60
monomer389-659
1×2IE;
Assess
Discovery of affinity-based probes for Btk occupancy assay
6n9p
monomer389-659
1×KHD;
Assess
Crystal structure of ARQ 531 in complex with the kinase domain of BTK
6e4f
monomer389-658
1×HRA; 2×IMD; 2×EDO;
Assess
Crystal structure of the noncovalently bonded complex of rilzabrutinib with BTK
7l5o
monomer389-658
1×R1L; 1×DMS; 1×PEG; 2×EDO; 1×SO4; 1×ACT;
Assess
Fragment-Based Discovery of a Novel Bruton's Tyrosine Kinase Inhibitor
7n5o
monomer389-658
1×IMD; 1×PGO; 1×0BQ; 1×EDO;
Assess
BTK1 SOAKED WITH COMPOUND 30
7kxq
monomer390-659
2×DMS; 1×X9Y;
Assess
BTK in complex with 25A
7r61
monomer390-659
1×2IJ; 2×DMS;
Assess
Fragment-Based Discovery of a Novel Bruton's Tyrosine Kinase Inhibitor
7n5r
monomer389-658
1×IMD; 1×EDO; 1×DMS; 1×0UW;
Assess
Bruton's tyrosine kinase in complex with 3-{[4-(1-acetylpiperidin-4-yl)phenyl]amino}-5-[(3R)-3-(3-m…
8ejb
monomer389-658
1×WKC; 2×EDO; 1×PD; 1×CL;
Assess
Fragment-Based Discovery of a Novel Bruton's Tyrosine Kinase Inhibitor
7n5x
monomer389-658
1×IMD; 1×PGO; 2×DMS; 1×0GW;
Assess
Crystal Structure of Bruton's Tyrosine Kinase bound to a Cinnoline Fragment
4zly
monomer389-658
2×IMD; 1×IPA; 1×DMS; 1×4RU;
Assess
Fragment-Based Drug Design of a Novel, Covalent Bruton's Tyrosine Kinase Inhibitor
7n5y
monomer389-658
1×IMD; 1×0CI; 1×DMS;
Assess
Bruton's tyrosine kinase (BTK) with compound 13
8e2m
monomer389-658
1×UB6; 1×PGE;
Assess
Crystal Structure of Bruton's Tyrosine Kinase in complex with a substituted Cinnoline
4zlz
monomer389-658
2×IMD; 1×IPA; 1×DMS; 1×4RV;
Assess
Crystal structure of BTK kinase domain complexed with 2-[4-(2-Diethylamino-ethoxy)-phenylamino]-6-(…
3pj2
monomer391-659
1×04K;
Assess
Crystal structure of BTK kinase domain complexed with 2-Methyl-5-[(E)-(3-phenyl-acryloyl)amino]-N-(…
3pj3
monomer391-659
1×04L;
Assess
Crystal structure of BTK kinase domain complexed with 3-(2,6-Dichloro-phenyl)-7-[4-(2-diethylamino-…
3pj1
monomer391-659
2×LHL;
Assess
Crystal structure of BTK kinase domain complexed with (5-Amino-1-o-tolyl-1H-pyrazol-4-yl)-[3-(1-met…
3piz
monomer391-659
1×03C;
Assess
CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT INHIBITOR
6di9
monomer392-659
1×GJJ; 1×DMS;
Assess
BTK In Complex With Inhibitor
6o8i
monomer391-658
1×LTJ;
Assess
Crystal structure of BTK kinase domain complexed with 2-Isopropyl-7-(4-methyl-piperazin-1-yl)-4-(5-…
3pix
monomer391-658
1×027;
Assess
BTK-inhibitor co-structure
5fbo
monomer392-659
1×5WH; 1×5WE;
Assess
Co-structure of BTK kinase domain with L-005085737 inhibitor
6x3n
monomer392-659
1×ULV; 1×5WE;
Assess
Crystal structure of the covalently bonded complex of rilzabrutinib with BTK
7l5p
monomer392-659
1×R1L; 2×SO4;
Assess
Bruton's tyrosine kinase in complex with a t-butyl cyanoacrylamide inhibitor
4yhf
monomer391-658
1×4C9; 9×NA; 2×EDO; 2×SO4; 3×CL;
Assess
BTK in complex with inhibitor N-(3-{[(2,6-dimethylphenyl)methyl]amino}-7-methoxyindeno[1,2-c]pyrazo…
6nfi
monomer392-659
1×KLP; 2×SO4;
Assess
Crystal structure of BTK kinase domain complexed with R406
3piy
monomer391-658
1×585;
Assess
Co-crystal structure of BTK kinase domain with Zanubrutinib
6j6m
monomer393-659
1×BA0; 1×IMD;
Assess
Bruton's tyrosine kinase in complex with compound 5
6vxq
monomer392-658
2×DMS; 1×RQS;
Assess
Bruton's tyrosine kinase in complex with compound 45
7n4q
monomer392-658
1×0B9;
Assess
Bruton's tyrosine kinase in complex with compound 6
6w06
monomer393-659
1×DMS; 1×DTT; 1×S5M;
Assess
Bruton's tyrosine kinase in complex with an orthosteric inhibitor
8flh
monomer392-658
2×DMS; 1×Y8H;
Assess
The 1.6 A crystal structure of human bruton's tyrosine kinase bound to a pyrrolopyrimidine-containi…
3gen
monomer392-658
1×B43;
Assess
BTK1 SOAKED WITH COMPOUND 5, Y551 IS SEQUESTERED
7kxl
monomer392-658
1×X9J; 3×DMS;
Assess
Structures of human Bruton's tyrosine kinase in active and inactive conformations suggests a mechan…
3k54
monomer392-658
1×1N1;
Assess
CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH FRAGMENT LIGAND
6di3
monomer393-659
1×GJA;
Assess
BTK1 COCRYSTALLIZED WITH IBRUTINIB
5p9j
monomer394-659
1×8E8;
Assess
BTK1 IN COMPLEX WITH CC 292
5p9l
monomer392-657
1×7G9;
Assess
BTK1 SOAKED WITH COMPOUND 26
7kxn
monomer394-659
1×X9P; 2×DMS;
Assess
Co-structure of BTK kinase domain with L-005298385 inhibitor
6x3p
monomer394-659
2×UM4; 1×EDO; 1×BTB;
Assess
Bruton's tyrosine kinase in complex with compound 1
6w07
monomer393-658
1×S9A; 1×DMS;
Assess
Bruton's tyrosine kinase in complex with compound 21
7n4r
monomer393-658
1×0BG; 1×DMS;
Assess
Bruton's tyrosine kinase in complex with compound 23
7lty
monomer393-658
1×YD7; 1×DMS;
Assess
BTK IN COMPLEX WITH GDC-0834
5p9f
monomer394-659
1×2VL; 4×EDO; 1×GOL;
Assess
BTK in complex with LOU064, a potent and highly selective covalent inhibitor
6tfp
monomer393-658
1×NA; 1×N6Z;
Assess
BTK complex with compound 12
6bkw
monomer393-657
3×SO4; 1×DXM; 1×FPZ; 2×GOL;
Assess
Bruton's tyrosine kinase in complex with compound 51
7ltz
monomer394-658
1×YDA; 1×DTT; 2×ACT;
Assess
Brutons tyrosine kinase in complex with compound 50.
6nzm
monomer395-659
1×L9S; 1×EDO;
Assess
Structure of BTK with RN486
5p9g
monomer394-658
1×7G6;
Assess
Co-structure of BTK kinase domain with L-005191930 inhibitor
6x3o
monomer395-659
1×ULY; 1×5WE;
Assess
BTK1 SOAKED WITH COMPOUND 24
7kxo
monomer395-659
1×X9S; 5×DMS;
Assess
Crystal structure of BTK kinase domain complexed with 4-Methanesulfonyl-N-(3-{8-[4-(morpholine-4-ca…
4ot6
monomer394-658
1×2V1;
Assess
Bruton's tyrosine kinase in complex with compound 65
7n4s
monomer394-658
1×0B0;
Assess
Bruton's tyrosine kinase in complex with an orthosteric inhibitor
8flg
monomer395-659
1×DMS; 1×Y8C;
Assess
Crystal structure of the human BTK kinase domain
3p08
monomer394-658
Assess
Bruton's tyrosine kinase (BTK) with pyridazinone compound 23
4rx5
monomer394-657
2×SO4; 2×GOL; 1×PG0; 1×3YO;
Assess
Bruton's tyrosine kinase (BTK) with pyridazinone compound 9
5kup
monomer394-657
2×SO4; 2×GOL; 1×PG0; 1×6XL;
Assess
Crystal structure of BTK kinase domain in complex with pirtobrutinib
8fll
monomer395-658
1×Y7W; 1×SO4; 2×GOL; 1×BTB;
Assess
Bruton's tyrosine kinase (BTK) with compound G-744
5vgo
monomer394-657
2×SO4; 2×GOL; 2×PG0; 1×9B1;
Assess
BTK kinase domain with inhibitor 1
5fbn
monomer395-658
1×5WF; 1×5WE; 1×CL;
Assess
BTK1 COCRYSTALLIZED WITH RN983
5p9h
monomer395-658
1×7G7;
Assess
CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6-(dimethylamino)-2-[2-(hydroxymethyl)-3-[1-m…
6hrp
monomer396-658
1×GMQ;
Assess
Crystal structure of BTK kinase domain complexed with 6-(dimethylamino)-8-fluoro-2-[2-(hydroxymethy…
4rfz
monomer396-658
1×3OV; 2×DMS;
Assess
BTK complex with compound 13
6bln
monomer395-657
3×SO4; 1×DY4; 1×GOL;
Assess
Crystal structure of BTK C481S kinase domain in complex with pirtobrutinib
8fln
monomer395-657
1×Y7W; 1×SO4; 2×GOL; 1×BTB;
Assess
CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 12-(6-tert-butyl-8-fluoro-1-oxo-phthalazin-2-…
6hrt
monomer396-658
1×GMW;
Assess
Crystal structure of Bruton agammabulinemia tyrosine kinase complexed with BMS-986142 aka (2s)-6-fl…
5t18
monomer396-658
1×73T;
Assess
Crystal structure of BTK kinase domain complexed with 1-[5-[3-(7-tert-butyl-4-oxo-quinazolin-3-yl)-…
4otq
monomer396-658
1×2V2; 2×DMS;
Assess
Crystal structure of BTK kinase domain complexed with 4-tert-Butyl-N-(3-{8-[4-(4-methyl-piperazine-…
4ot5
monomer396-658
1×481; 2×DMS;
Assess
BTK Fluorocyclopropyl amide inhibitor, Compound 25
6xe4
monomer395-657
1×V1G; 2×SO4;
Assess
CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI2815
6aub
monomer395-657
2×SO4; 1×BXM;
Assess
CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI2625
6aua
monomer394-656
1×GOL; 2×SO4; 1×BXJ;
Assess
Crystal structure of BTK kinase domain complexed with 6-(dimethylamino)-2-[2-(hydroxymethyl)-3-[1-m…
4rfy
monomer396-658
1×3OU; 2×DMS;
Assess
BTK complex with compound 7
6bik
monomer395-657
3×SO4; 1×DTJ; 1×GOL;
Assess
BTK complex with compound 10
6bke
monomer395-657
3×SO4; 1×DVJ;
Assess
Crystal structure of BTK kinase domain complexed with 6-cyclopropyl-2-[3-[5-[[5-(4-ethylpiperazin-1…
4otr
monomer396-658
1×2V3; 2×DMS;
Assess
Crystal structure of bruton's tyrosine kinase mutant V555R in complex with dasatinib
3oct
monomer394-656
1×1N1;
Assess
Crystal structure of BTK kinase domain complexed with N-[2-methyl-3-[4-methyl-6-[4-(4-methylpiperaz…
6ep9
monomer396-658
1×BNB;
Assess
Crystal structure of BTK kinase domain complexed with 2-[8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-…
4rg0
monomer396-658
1×3P0;
Assess
BTK complex with compound 11
6bkh
monomer396-657
4×SO4; 1×DVD;
Assess
Crystal structure of bruton's tyrosine kinase in complex with inhibitor CGI1746
3ocs
monomer395-656
3×SO4; 1×BME; 1×746;
Assess
BTK in complex with an inhibitor
6s90
monomer395-656
1×L0Z;
Assess
Crystal structure of the kinase domain of Bruton's Tyrosine kinase with GDC0834
4otf
monomer396-657
3×SO4; 1×2VL;
Assess
Crystal structure of Bruton agammaglobulinemia tyrosine kinase complexed with BMS-809959 aka 4-tert…
4nwm
monomer396-657
1×2P5;
Assess
Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R…
5bpy
monomer396-657
1×4UQ;
Assess
Crystal structure of bruton's tyrosine kinase in complex with inhibitor 2e
5zz4
monomer395-655
1×9M3;
Assess
The PH domain of Bruton's tyrosine kinase mutant R28C
6tt2
monomer2-169
1×MG; 1×ZN;
Assess
Crystal Structure of 1-methylindoline-2,3-dione covalently bound to the PH domain of Bruton's tyros…
6tse
monomer2-169
1×MG; 3×72V; 1×ZN;
Assess
Crystal Structure of 5-chloroindoline-2,3-dione covalently bound to the PH domain of Bruton's tyros…
6yyf
monomer2-169
1×3IS; 1×ZN; 1×MG;
Assess
Crystal Structure of 5-(trifluoromethoxy)indoline-2,3-dione covalently bound to the PH domain of Br…
6yyg
monomer2-169
1×Q1B; 1×MG; 1×ZN;
Assess
Crystal Structure of 1,5-dimethylindoline-2,3-dione covalently bound to the PH domain of Bruton's t…
6yyk
monomer2-169
1×ZN; 1×MG;
Assess
The PH domain of Bruton's tyrosine kinase mutant R28C
6tuh
monomer2-168
2×NXT; 1×MG; 1×ZN;
Assess
Crystal Structure of 5-bromoindoline-2,3-dione covalently bound to the PH domain of Bruton's tyrosi…
6tvn
monomer2-168
1×NYQ; 1×ZN; 1×MG;
Assess
Crystal structure of PH domain of Bruton's tyrosine kinase
2z0p
monomer2-168
1×ZN; 1×4PT;
Assess
Solution Structures of the SH2 domain of Bruton's Tyrosine Kinase
2ge9
monomer270-387
Assess
SH3 DOMAIN FROM BRUTON'S TYROSINE KINASE, NMR, MINIMIZED AVERAGE STRUCTURE
1awx
monomer211-275
Assess
SH3 DOMAIN FROM BRUTON'S TYROSINE KINASE, NMR, 42 STRUCTURES
1aww
monomer211-275
Assess
NMR Study of the SH3 Domain From Bruton's Tyrosine Kinase, 20 Structures
1qly
monomer216-273
Assess

5 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4xi2.1.Amonomer0.77214-657
1×AU;98.21
Assess
4k11.1.Amonomer0.71218-656
38.57
Assess
1opl.2.Amonomer0.69275-657
39.82
Assess
1y57.1.Amonomer0.69216-656
38.62
Assess
4y93.1.Amonomer0.611-658
1×ZN;95.96
Assess

5 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24xi2.1.Amonomer0.76248-691
1×AU;98.21
Assess
Isoform 24k11.1.Amonomer0.71252-690
38.57
Assess
Isoform 21opl.2.Amonomer0.69309-691
39.82
Assess
Isoform 21y57.1.Amonomer0.69250-690
38.62
Assess
Isoform 24y93.1.Amonomer0.6135-692
1×ZN;96.40
Assess